SpaceX looks set to rise before its July 7 Nasdaq-100 inclusion, as passive index buying, a low float and options-driven gamma squeezes power the stock. CRSP, FTSE Russell and MSCI inclusions also force buying regardless of valuation; above $225 it could reach $300, about $4 trillion. After that, the stance turns bearish: as lockups expire and the float grows from about 5%, early investors' selling should overwhelm buying for a loss-making company, so long-term buyers could wait a year. x.com  … Show more

China SXT Pharmaceuticals is a short-squeeze candidate: short interest exceeds 20%, institutional ownership exceeds 100%, no shares are left to borrow and the cost to borrow is over 500%. It has the same setup as other low-float, high-short-interest plays; after coiling all day, a pop on incoming volume is only a matter of time because shorts are trapped. x.com  x.com 

FGI Industries' low float and last week's earnings are fueling a squeeze, making it the top gainer this morning. x.com  x.com